Clinical trials
Feeding and Eating Disorders trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Unknown status | 3 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ARCIM Institute Academic Research in Complementary and Integrative Medicine | 2 |
| Forschungsinstitut der Diabetes Akademie Mergentheim | 2 |
| Heidelberg University | 1 |
| Prof. Dr. Katrin Giel | 1 |
| University Hospital Tuebingen | 1 |
| University Medical Center Goettingen | 1 |
| University of Erlangen-Nürnberg Medical School | 1 |
| Vivantes Netzwerk für Gesundheit GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Feeding and Eating Disorders | 10 |
| Anorexia Nervosa | 4 |
| Anxiety Disorders | 4 |
| Binge-Eating Disorder | 2 |
| Bulimia Nervosa | 2 |
| Diabetes Mellitus | 2 |
| Mental Disorders | 2 |
| Personality Disorders | 2 |
| Anorexia | 1 |
| Bipolar Disorder | 1 |
Trials
Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.